Category: Metabolic and Bariatric Surgery

Low-Dose Haloperidol Effectively Reduces Postoperative Nausea/Vomiting in Bariatric Surgery

In the pursuit of countering postoperative nausea and vomiting (PONV) among bariatric surgery patients, researchers integrated low-dose haloperidol into enhanced recovery protocols. Analyzing data from 475 patients, they found that those who received haloperidol had lower rates of PONV, required fewer additional antiemetics, and experienced significantly shorter hospital stays. This innovative approach not only eases […]